ghk-cu peptide sublingual Beauty NEW! 𧬠First-Ever, At-Home, Needle-Free
Description
Researchers at the University of Zagreb first isolated and characterized this compound in 1993, initiating decades of preclinical investigation
Other medications the patient may be takingincluding certain antibiotics, anticonvulsants, or immunomodulatory agentsshould be reviewed
This AMP was also reported to trigger neutrophils to produce ectosomes (antimicrobial microvesicles), demonstrating the potential therapeutic potential of cathelicidin LL-37
Keep sealed until required for laboratory use
